Page 65 - Testing Lab News Today

Indianapolis-based TechPoint has unveiled the nominees for the 2021 Mira Awards, honoring the

Will Personalized Companion Diagnostics become the norm for diagnostics? Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is finally moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future. But COVID-19 is impacting healthcare treatment everywhere and lowering demand for specialized cancer testing. Find out the latest outlook for thi...

AV-Comparatives rated as most trustworthy and reliable independent IT Security Test Lab Share Article Security Survey 2021 - AV-Comparatives "We are proud, that users rated AV-Comparatives as most trustworthy and reliable independent IT Security Test Lab. We will continue or high-quality testing, and introduce new tests during this year." - Peter Stelzhammer, co-founder, AV-Comparatives INNSBRUCK, Austria and AUSTIN, Texas (PRWEB) ...

West Virginia residents are now able to register for access to medical marijuana, but the state still needs to partner with a testing lab before the product can be put on the market.

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Me...

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitor...

4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ...

Share this article Share this article ResearchAndMarkets.coms offering. The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians offices and elsewhere. And lets not forget the screening market, ...

While many factors have led to Cornell’s success to date in managing the spread of COVID-19 on campus, one unsung aspect has been the university’s commitment to analyze and learn, to pivot and adapt. Senior-level committees – working in close collaboration with the Tompkins County Health Department and Cayuga Medical Center – have met steadily throughout the pandemic to assess Cornell’s COVID-19 plan, and have suggested improvements that have shaped Cornell’s proce...

Date Time Spring tweaks to COVID-19 plan are based on fall’s lessons While many factors have led to Cornell’s success to date in managing the spread of COVID-19 on campus, one unsung aspect has been the university’s commitment to analyze and learn, to pivot and adapt. Senior-level committees – working in close collaboration with the Tompkins County Health Department and Cayuga Medical Center – have met steadily throughout the pandemic to assess Cornell’s COVID-19 plan, and have sugg...